🧔♂️ A friendly human may check it before it goes live. More news here
Alphabet-backed Isomorphic Labs raises $5b series C
Isomorphic Labs, a London-based AI drug discovery company backed by Alphabet, announced a US$5 billion series C on November 17. Greenoaks and Sequoia Capital co-led the round.
The funding will support its AI models, biology research, and clinical development infrastructure as it advances drug candidates toward human trials.
Isomorphic Labs was founded in 2021 as a spinout from Google DeepMind, Alphabet’s AI research unit.
Isomorphic previously raised US$2.1 billion in a May 2026 series B. It is also ranked among the most heavily funded startups in AI drug discovery.
Isomorphic said it had positive preclinical results in oncology, immunology, and programs with partners. Its 2024 collaborations with Eli Lilly and Novartis had a combined potential value of nearly US$3 billion.
In January 2026, its clinical trial timeline had been delayed. In the latest announcement, Isomorphic said its first therapeutic programs were still progressing toward trials.
🔗 Source: Isomorphic Labs




